Ignite Creation Date:
2025-12-25 @ 3:33 AM
Ignite Modification Date:
2026-01-12 @ 10:22 AM
Study NCT ID:
NCT03052205
Status:
COMPLETED
Last Update Posted:
2020-02-11
First Post:
2017-02-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Intratumoral IMO-2125 in Patients With Refractory Solid Tumors
Sponsor:
Idera Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-09
Start Date Type:
ACTUAL
Primary Completion Date:
2019-07-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-10-04
Completion Date Type:
ACTUAL
First Submit Date:
2017-02-06
First Submit QC Date:
None
Study First Post Date:
2017-02-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-10
Last Update Post Date:
2020-02-11
Last Update Post Date Type:
ACTUAL